Found 13 results

2010
ADVANCE Collaborative Group, Writing Committee, Kengne AP, Patel A, Colagiuri S, Heller S, Hamet P, Marre M, Pan CY, Zoungas S et al..  2010.  The Framingham and UK Prospective Diabetes Study (UKPDS) risk equations do not reliably estimate the probability of cardiovascular events in a large ethnically diverse sample of patients with diabetes: the Action in Diabetes and Vascular Disease: Preterax. Diabetologia. Epub. [IF 6.418]
2009
ADVANCE Collaborative Group, Writing Committee, Ninomiya T, Perkovic V, de Galan B, Zoungas S, Pillai A, Jardine M, Patel A, Cass A et al..  2009.  Albuminuria and kidney function independently predict cardiovascular and renal outcomes in diabetes. J Am Soc Nephrol. 20:1813-21.[IF7.111]..
ADVANCE Collaborative Group, Writing Committee, Kengne A-P , Czernichow S , Huxley R , Grobbee D, Woodward M, Neal B, Zoungas S, Cooper M et al..  2009.  Blood pressure variables and cardiovascular risk: New findings from ADVANCE.. Hypertension. 54:399-404.[IF7.368]..
ADVANCE Collaborative Group, de Galan BE, Zoungas S, Chalmers J, Anderson C, Dufouil C, Pillai A, Cooper M, Grobbee DE, Hackett M et al..  2009.  Cognitive function and risks of cardiovascular disease and hypoglycaemia in people with type 2 diabetes; the ADVANCE trial. Diabetelogia. 52:2329-36.[IF6.418].
ADVANCE Collaborative Group, Writing Committee, Zoungas S, de Galan BE, Ninomiya T, Grobbee D, Hamet P, Heller S, Macmahon S, Marre M et al..  2009.  The combined effects of routine blood pressure lowering and intensive glucose control on macrovascular and microvascular outcomes in patients with type 2 diabetes; new results from ADVANCE. Diabetes Care. 32:2068-74.[IF7.349].
ADVANCE Collaborative Group, Du X, Ninomiya T, de Galan B, Abadir E, Chalmers J, Pillai A, Woodward M, Cooper M, Harrap S et al..  2009.  Risk of cardiovascular events and effects of routine blood pressure lowering among patients with type 2 diabetes and artrial fibrillation . results of the ADVANCE study. Eur Heart J. 30 :1128-35.[IF7.924]..
ADVANCE Collaborative Group, de Galan BE, Perkovic V, Ninomiya T, Pillai A, Patel A, Cass A, Neal B, Poulter N, Harrap S et al..  2009.  Routine blood pressure lowering and kidney disease in type 2 diabetes. J Am Soc Nephrol. 20:883-92.[IF7.111].
2008
ADVANCE Collaborative Group, (Writing Committee), Chalmers J, Joshi R, Kengne A-P, Ninomiya T, Bi Y, Bompoint S, Billot L, Patel A.  2008.  Efficacy and safety of fixed combination of perindopril and indapamide in type 2 diabetes: results from ADVANCE in context of evidence available in 2007 . J Hypertens . 26 :S21-S27.[IF4.364].
ADVANCE Collaborative Group, (Writing Committee), Patel A, MacMahon S, Chalmers J.  2008.  Intensive glucose control in type 2 diabetes . Reply. N Engl J Med. 359:1520-1.[IF52.589].
ADVANCE Collaborative Group, (Writing Committee), Patel A, MacMahon S, Neal B, Billot L, Chalmers J.  2008.  The ADVANCE trial . Author.s reply. Lancet. 371:26.[IF28.638].
2007
Patel A, ADVANCE Collaborative Group, (Writing Committee), MacMahon S, Chalmers J, Neal B, Woodward M, Billot L, Harrap S, Poulter N et al..  2007.  Effects of a fixed combination of perindopril and indapamide on macrovascular and microvascular outcomes in patients with type 2 diabetes mellitus (the ADVANCE trial): a randomised controlled trial. Lancet . 370:829-40.[IF28.638].
ADVANCE Collaborative Group, (Writing Committee), Glasziou P, Alexander J, Beller E, Clarke P, J C, MacMahon S, (Chair).  2007.  Which health-related quality of life score? A comparison of alternative utility measures in patients with Type 2 diabetes win the ADVANCE trial Health Qual Life Outcomes. 5:21.[IF0].
2006
ADVANCE Collaborative Group, (Writing Committee), Perkovic V, Joshi R, Patel A, Bompoint S, Chalmers J.  2006.  ADVANCE: lessons from the run-in phase of a large study in type 2 diabetes. Blood Press . 15:340-6.[ImpactFactor1.391].

Latest News

Recently added pages

Our focus

George Institute sites